DNER and neoplasm: BET inhibitors such as JQ1 and I-BET762 suppress M2-like programming, shifting TAMs toward an anti-tumor M1-like phenotype by downregulating immunosuppressive genes and reducing recruitment of M2-like macrophages (5, 54, 94, 96).